[visceral mycoses in intensive care]

NLM AIDSLINE [Visceral mycoses in intensive care] Antonov VB
August 30, 1999

Anesteziol Reanimatol. 1999 Mar-Apr;(2):41-5. Unique Identifier : Mycotic involvement of viscera and nervous system develops in patients with immunodeficiency, during antibiotic treatment, and application of invasive methods of diagnosis and treatment, promoting penetration of the agent into the blood, which often results in development of mycotic foci in the visceral parenchyma and nervous system. The involvement is diagnosed from resistance to common therapy and is verified by laboratory investigations: microscopic examination of biological substrates, inoculation in nutrient media, serological tests, and histological analysis of biopsy specimens. Etiotropic therapy is carried out by antimycotic drugs with due regard for the agent sensitivity, drug pharmacokinetics, and drug tolerance. Antimycotic therapy should be carried out by a physician with at least the minimal knowledge of mycology. JOURNAL ARTICLE Acquired Immunodeficiency Syndrome/COMPLICATIONS Adult Aged Antibiotics/THERAPEUTIC USE Antifungal Agents/THERAPEUTIC USE Asthma/COMPLICATIONS AIDS-Related Opportunistic Infections/THERAPY Endocrine Diseases/COMPLICATIONS English Abstract Female Genital Diseases, Female/COMPLICATIONS Human HIV Infections/COMPLICATIONS Iatrogenic Disease Infant, Newborn Intensive Care Male Mycoses/DIAGNOSIS/ETIOLOGY/THERAPY Risk Factors Transplantation/ADVERSE EFFECTS

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 OHIO: Phila Health Department HIV Testing Well-Received CONNECTICUT: City's Circle Care Center is a Model for HIV Prevention UNITED STATES: New Compound Excels at Killing Persistent and Drug-Resistant Tuberculosis INDIA: India Faces TB Drug Shortage, Warns International Medical Org ALASKA: After Topping List for Chlamydia Rates, Alaska Seeing Some Improvement Tanzania: Police Abuse, Torture, Impede HIV Services Growing HIV/AIDS awareness in Indonesia's Papua region South Africa: Catastrophe as Eastern Cape drug stock-outs continue Community-led programmes critical to progress on AIDS in Sri Lanka One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs CONNECTICUT: City's Circle Care Center is a Model for HIV Prevention SOUTH CAROLINA: DHEC Asks 500 Tri-County Spinal Care Center Patients to Be Tested for Hepatitis B, Hepatitis C and HIV CountyCare Offers Historic Opportunity to Improve Care for People with HIV CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance MARYLAND: People More Likely to Keep HIV Clinic Appointments if They Believe Their Care Providers Know Them as a Person NEW JERSEY: Middlesex County to Receive $1M to Support HIV/AIDS Care MET-Rx® Launches MET-Rx® Cares U.S. Charitable Giving Program NORTH CAROLINA: N.C. Bill Regarding Minors' Health Care, Privacy Spurs Debate NORTH CAROLINA: N.C. Bill Regarding Minors' Health Care, Privacy Spurs Debate
Information in this article was accurate in August 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.